This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Thyroid/ Parathyroid Diseases  • Prognosis/ Outcomes  • Otolaryngology/ Head & Neck Surgery  • Endocrine Disease of Head & Neck  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Giorgio Iervasi, MD; Sabrina Molinaro, PhD; Patrizia Landi, BSc; Maria Chiara Taddei, BSc; Elena Galli, MD; Fabio Mariani, PhD; Antonio L’Abbate, MD; Alessandro Pingitore, MD, PhD

Arch Intern Med. 2007;167(14):1526-1532.

Background  The effects of subclinical thyroid dysfunction on cardiac outcome are not well defined.

Methods  To assess the relationship between mild thyroid dysfunction and the incidence of death in cardiac patients, we evaluated 3121 cardiac patients. Cardiac and overall deaths were considered. Four groups were defined: euthyroidism, subclinical hypothyroidism (SCH), subclinical hyperthyroidism (SCT), and low triiodothyronine syndrome (low T₃).

Results  After mean follow-up of 32 months, there were 65 and 140 cardiac and overall deaths (3.4% and 7.3%), respectively, in euthyroidism, 15 and 27 (7.2% and 13.0%) in SCH, 8 and 9 (8.2% and 9.2%) in SCT, and 59 and 119 (6.5% and 13.1%) in low T₃. Survival rates for cardiac death were lower in SCH, SCT, and low T₃ than in euthyroidism (log-rank test; ² = 19.46; P < .001). Survival rates for overall death were lower in SCH and low T₃ than in euthyroidism (log-rank test; ² = 26.67; P < .001). After adjustment for several risk factors, hazard ratios (HRs) for cardiac death were higher in SCH (HR, 2.40; 95% confidence interval [CI], 1.36-4.21; P = .02), SCT (HR, 2.32; 95% CI, 1.11-4.85; P = .02), and low T₃ (HR, 1.63; 95% CI, 1.14-2.33; P = .007) than in euthyroidism; HRs for overall death were higher in SCH (HR, 2.01; 95% CI, 1.33-3.04; P < .001) and low T₃ (HR, 1.57; 95% CI, 1.22-2.01; P < .001) but not in SCT.

Conclusion  A mildly altered thyroid status is associated with an increased risk of mortality in patients with cardiac disease.

Author Affiliations: Clinical Physiology Institute (Drs Iervasi and Pingitore and Mss Landi and Taddei) and Epidemiology and Biostatistics Section (Drs Molinaro and Mariani), National Council of Research, and Scuola Superiore di Studi Universitari S’Anna (Drs Galli and L’Abbate), Pisa, Italy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies
Haentjens et al.
Eur J Endocrinol 2008;159:329-341.
ABSTRACT | FULL TEXT  

Should we treat all subjects with subclinical thyroid disease the same way?
Biondi
Eur J Endocrinol 2008;159:343-345.
FULL TEXT  

Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease
Chonchol et al.
CJASN 2008;3:1296-1300.
ABSTRACT | FULL TEXT  

The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area
Dorr et al.
Eur J Endocrinol 2008;159:145-152.
ABSTRACT | FULL TEXT  

Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs et al.
ANN INTERN MED 2008;148:832-845.
ABSTRACT | FULL TEXT  

Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Asvold et al.
Arch Intern Med 2008;168:855-860.
ABSTRACT | FULL TEXT